The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study (Q44487823)

3 December 2017

The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study (English)

1 reference

chronic renal insufficiency

3 December 2017

1 reference

1 reference

Pablo Molina

1

1 reference

3 December 2017

José L Górriz

2

1 reference

3 December 2017

Mariola D Molina

3

1 reference

3 December 2017

Ana Peris

4

1 reference

3 December 2017

Sandra Beltrán

5

1 reference

3 December 2017

Julia Kanter

6

1 reference

3 December 2017

Verónica Escudero

7

1 reference

3 December 2017

Ramón Romero

8

1 reference

3 December 2017

Luis M Pallardó

9

1 reference

3 December 2017

language of work or name

English

0 references

publication date

24 August 2013

1 reference

Nephrology Dialysis Transplantation

3 December 2017

1 reference

3 December 2017

29

1 reference

3 December 2017

97-109

1 reference

3 December 2017

1

1 reference

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

3 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Relation between kidney function, proteinuria, and adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Hypovitaminosis D in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

25-hydroxyvitamin D levels, race, and the progression of kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Vitamins K and D status in stages 3-5 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Chronic kidney disease, hypovitaminosis D, and mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Vitamin D and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Vitamin D supplementation in pre-dialysis chronic kidney disease: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

KHA-CARI guideline: Early chronic kidney disease: detection, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Changes in albuminuria predict mortality and morbidity in patients with vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Intracellular calcium homeostasis in patients with early stages of chronic kidney disease: effects of vitamin D3 supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

Vitamin D levels and patient outcome in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT360

21 January 2018

Identifiers

DOI

10.1093/NDT/GFT360

1 reference

3 December 2017

1 reference